[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2017 UK Hospital Clinical Chemistry and Immunodiagnostic Markets

March 2017 | 523 pages | ID: 2BEFC7CE0DEEN
Venture Planning Group

US$ 3,465.00 US$ 3,850.00 -10 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This new report from VPGMarketResearch contains 523 pages, 64 tables, and presents a comprehensive analysis of the UK hospital clinical chemistry and immunodiagnostics market, including:
  • Major issues pertaining to the UK clinical chemistry and immunodiagnostic hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
  • Five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in UK hospitals, including controls, calibrators and consumables.
  • Five-year volume forecasts for serum, whole blood, plasma, CFS, urine and other specimens.
  • Five-year reagent and instrument sales forecasts.
  • Review of current instrumentation technologies, and a feature comparison of high-, medium-, and low-volume/POC analyzers.
  • Sales and market shares of leading reagent and instrument suppliers.
  • Review of current and emerging technologies and their potential market applications.
  • Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables.
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Market penetration strategies, entry barriers and risks.
  • Contains 523 pages and 64 tables
    INTRODUCTION

    WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

    A. Major Routine Chemistry Tests
      1. Albumin
      2. Alkaline Phosphatase
      3. ALT/SGPT
      4. Ammonia
      5. Amylase
      6. AST/SGOT
      7. Bilirubin, Total
      8. Blood Gases
      9. Blood Urea Nitrogen (BUN)
      10. Calcium
      11. Cardio CRP
      12. Cholesterol
      13. Cholinesterase
      14. CRP
      15. Creatinine
      16. Electrolytes
        a. Carbon Dioxide/Bicarbonate
        b. Chloride
        c. Potassium
        d. Sodium
      17. Ferritin
      18. Fructosamine
      19. Gamma-Glutamyl Transpeptidase (GGT)
      20. Glucose
      21. High Density Lipoprotein (HDL)
      22. Homocysteine
      23. Iron
      24. Lactate Dehydrogenase (LDH)
      25. Magnesium
      26. Phosphorus
      27. Protein
      28. Triglycerides
      29. Uric Acid
      30. Troponin
    B. Therapeutic Drug Monitoring (TDM)
      1. Overview
      2. Carbamazepine
      3. Cyclosporin
      4. Digoxin
      5. Everolimus
      6. Gentamicin
      7. Lamotrigine/Lamictal
      8. Levetiracetam
      9. Lidocaine
      10. Lithium
      11. NAPA/Procainamide
      12. Phenytoin
      13. Quinidine
      14. Sirolimus
      15. Tacrolimus
      16. Theophylline
      17. Topirimate
      18. Valproic Acid
    C. Endocrine Function Tests
      1. Cortisol
      2. Estradiol
      3. Follicle-Stimulating Hormone (FSH)
      4. Gastrin
      5. Growth Hormone/IGF-1
      6. Human Chorionic Gonadotropin (HCG)
      7. LH
      8. Progesterone
      9. PTH/IPTH
      10. Prolactin
      11. T3
      12. T3 Free
      13. T3 Uptake
      14. T4 (Thyroxine)
      15. T4 Free
      16. TBG
      17. Testosterone
      18. Thyroglobulin Ab
      19. TP-Ab
      20. TSH
    D. Tumor Markers And Special Chemistry Tests
      1. AFP
      2. CA 15-3
      3. CA 19-9
      4. CA 27-29
      5. Carcinoembrionic Antigen (CEA)
      6. Folate/Folic Acid
      7. HCG
      8. 25-Hydroxy Vitamin D2 and D3
      9. Occult Blood
      10. Prostate-Specific Antigen (PSA)
      11. Thyroglobulin
      12. Vitamin B-12
    E. Immunoprotein Tests
      1. Complement
        a. C3
        b. C4
      2. Free Light Chains
      3. Immunofixation
      4. Immunoglobulins (IgA, IgE, IgG, IgM)
      5. Haptoglobin
      6. Prealbumin
      7. Protein Electrophoresis
    F. Drugs of Abuse
      1. Overview
      2. Test Methodologies
      3. Amphetamines
      4. Barbiturates
      5. Benzodiazepines
      6. Cannabinoids/Marijuana
      7. Cocaine
      8. Lysergic Acid Diethylamide (LSD)
      9. Methadone
      10. Methaqualone
      11. Opiates
      12. Phencyclidine
      13. Tricyclic Antidepressants
    G. Instrumentation Review: Operating Characteristics and Features of High-, Medium-, and Low- Volume/POC Analyzers Manufactured By:
      Abaxis
      Abbott
      Alere/Inverness
      Alfa Wassermann
      AMS
      Awareness Technologies
      Beckman Coulter/Olympus
      Binding Site
      bioMerieux
      Carolina Chemistries
      DiaSorin
      Grifols
      Horiba
      Medica
      Nova Biomedical
      Ortho-Clinical Diagnostics
      Polymedco
      Randox
      Roche
      Siemens
      Tosoh
      Vital Diagnostics
    H. Major In Vitro Diagnostic Technologies And Their Potential Applications
      1. Monoclonal and Polyclonal Antibodies
      2. Immunoassays
        a. Technological Principle
        d. Chemiluminescence
        c. Enzyme Immunoassays (EIA)
          Overview
          ELISA
          EMIT
          Electrochemical
        d. Radioimmunoassays (RIA)
        e. Immunoprecipitation
        f. Affinity Chromatography
      3. Tandem Mass Spec
      4. IT and Automation
      5. Dry Chemistry   6. Biosensors

    U.K.

    A. Executive Summary
    B. Business Environment
    C. Market Structure
    D. Market Size, Growth and Major Suppliers' Instrument and Reagent Sales and Market Shares

    MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

    DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

    ALTERNATIVE MARKET PENETRATION STRATEGIES

    A. Internal Development
    B. Collaborative Arrangements
    C. University Contracts
    D. Distribution Strategies for Decentralized Testing Markets
      1. Marketing Approaches
      2. Product Complexity
      3. Customer Preference
      4. Established Suppliers
      5. Emerging Suppliers
      6. Major Types of Distributors
      7. Market Segmentation

    POTENTIAL MARKET ENTRY BARRIERS AND RISKS

    A. Market Maturity
    B. Cost Containment
    C. Competition
    D. Technological Edge and Limitations
    E. Patent Protection
    F. Regulatory Constraints
    G. Decentralized Testing Market Challenges

    COMPETITIVE ASSESSMENTS

    Abbott Laboratories
    AdnaGen
    Beckman Coulter/Danaher
    Biomedical Diagnostics
    BioMerieux
    Bio-Rad
    Dako
    DiaSorin
    Eiken
    Fujirebio Instrumentation Laboratory
    Kyowa Medex
    Matritech
    Ortho-Clinical Diagnostics
    Roche
    Siemens
    Sysmex
    Thermo Fisher
    Tosoh
    Wako
    Wallac/PE

    LIST OF TABLES

    Major Companies Developing or Marketing Albumin Tests
    Major Companies Developing or Marketing Alkaline Phosphatase Tests
    Major Companies Developing or Marketing ALT/SGPT Tests
    Major Companies Developing or Marketing Amylase Tests
    Major Companies Developing or Marketing AST/SGOT Tests
    Major Companies Developing or Marketing Bilirubin Tests
    Major Companies Developing or Marketing Blood Gas Analyzers
    Major Companies Developing or Marketing BUN Tests
    Major Companies Developing or Marketing Calcium Tests
    Major Companies Developing or Marketing Cholesterol Tests
    Major Companies Developing or Marketing Creatinine Tests
    Major Companies Developing or Marketing Electrolyte Tests
    Major Companies Developing or Marketing GGT Tests
    Major Companies Developing or Marketing Glucose Tests
    Major Companies Developing or Marketing HDL Tests
    Major Companies Developing or Marketing Iron Tests
    Major Companies Developing or Marketing LDH Tests
    Major Companies Developing or Marketing Magnesium Tests
    Major Companies Developing or Marketing Phosphorus Tests
    Major Companies Developing or Marketing Protein Tests
    Major Companies Developing or Marketing Triglycerides Tests
    Major Companies Developing or Marketing Uric Acid Tests
    Major Companies Developing or Marketing TDM Tests
    Major Companies Developing or Marketing Digoxin Tests
    Major Companies Developing or Marketing Lithium Tests
    Major Companies Developing or Marketing Phenytoin Tests
    Major Companies Developing or Marketing Theophylline Tests
    Major Companies Developing or Marketing Valproic Acid Tests
    Major Companies Developing or Marketing FSH Tests
    Major Companies Developing or Marketing HCG Tests
    Major Companies Developing or Marketing LH Tests
    Major Companies Developing or Marketing Prolactin Tests
    Major Companies Developing or Marketing T3 Tests
    Major Companies Developing or Marketing T4 Tests
    Major Companies Developing or Marketing TSH Tests
    Major Companies Developing or Marketing AFP Tests
    Major Companies Developing or Marketing CEA Tests
    Major Companies Developing or Marketing Ferritin Tests
    Major Companies Developing or Marketing Occult Blood Tests
    Major Companies Developing or Marketing Prostatic Acid Phosphatase Tests
    Major Companies Developing or Marketing PSA Tests
    Major Companies Developing or Marketing Vitamin B-12/Folate Tests
    Major Companies Developing or Marketing CRP Tests
    Major Companies Developing or Marketing Drugs of Abuse Tests
    Major Companies Developing or Marketing Biosensors for Clinical Chemistry Testing
    Executive Summary Table: U.K., Clinical Chemistry and Immunoassay Test Volume And Diagnostics Sales Forecast By Test Category
    U.K., Hospital Laboratories Performing Chemistry and Immunoassay Tests By Bed Size
    U.K., Hospital Laboratories, Profiles, Panels and Individual Tests Forecast
    U.K., Hospital Laboratories, Routine Chemistry Test Volume Forecast by Assay
    U.K., Hospital Laboratories, Endocrine Function Test Volume Forecast by Assay
    U.K., Hospital Laboratories, Tumor Markers and Special Chemistry Test Volume Forecast by Assay
    U.K., Hospital Laboratories, Immunoprotein Test Volume Forecast by Assay
    U.K., Hospital Laboratories, TDM Test Volume Forecast by Assay
    U.K., Hospital Laboratories, Drugs of Abuse Test Volume Forecast by Assay
    U.K., Clinical Chemistry and Immunoassay Calibrator and Control Market Forecast By Test Category
    U.K., Hospital Laboratories, Routine Chemistry Reagent Market Forecast by Assay
    U.K., Hospital Laboratories, Endocrine Function Reagent Market Forecast by Assay
    U.K., Hospital Laboratories, Immunoprotein Reagent Market Forecast by Assay
    U.K., Hospital Laboratories, TDM Reagent Market Forecast by Assay
    U.K., Hospital Laboratories, Tumor Markers and Special Chemistry Reagent Market Forecast by Assay
    U.K., Hospital Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
    U.K., Clinical Chemistry and Immunoassay Instrument Market Forecast By Analyzer Type
    U.K., Major Suppliers of Clinical Chemistry Diagnostic Products, Estimated Sales and Market Shares
    U.K., Major Suppliers of Immunoassay Diagnostic Products, Estimated Sales and Market Shares


    More Publications